Where to buy Ponatinib

Ponatinib (Ponatinib) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with: chronic phase (CP) chronic myeloid cell disease that is resistant or intolerant to at least two prior kinase inhibitors. CML, accelerated phase (AP) or blast phase (BP) CML without other indications for kinase inhibitors, or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL), T315I-positive CML (chronic phase, accelerated phase, or blast phase), or T315I-positive Ph+ALL.

Multi-targeted inhibitors such as ponatinib, used alone or in combination with other drugs targeting other RTKs or cancer-related pathways, offer the opportunity to inhibit cancer progression. There is a reported risk of vaso-occlusive events (arterial and venous thrombosis and occlusion, including fatal myocardial infarction, stroke, stenosis of large cerebral arteries, severe peripheral vascular disease, and the need for emergency revascularization surgery) and heart failure with ponatinib.

The original drug of Ponatinib has not yet been launched in China, so it is not included in the medical insurance. Domestic patients in need may only purchase it through overseas channels. The Hong Kong original version of Ponatinib specificationsThe price of 45mg*30 tablets per box may be around 40,000 yuan (the price may fluctuate due to the exchange rate), which is expensive. There are also generic ponatinib drugs produced in other countries, which are relatively cheap. The price of 45mg*30 tablets per box produced by Everest Pharmaceutical Factory in Bangladesh may be around 4,000 yuan (the price may fluctuate due to the exchange rate). Its drug ingredients are basically the same as those of the original drug. For more drug information and specific prices, please consult the medical consultant of Yaode.